Abrocitinib 100 mg versus 200 mg for atopic dermatitis: a meta-analysis of randomized controlled trials

INTRODUCTION: It is elusive to compare the efficacy and safety of abrocitinib 100 mg versus 200 mg once daily in patients with atopic dermatitis. AIM: This meta-analysis aims to explore the influence of abrocitinib 100 mg versus 200 mg on the treatment of atopic dermatitis. MATERIAL AND METHODS: Sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Junqiao, Yang, Yuanjuan, Yang, Haitao, Fu, Xiaojuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704456/
https://www.ncbi.nlm.nih.gov/pubmed/36457683
http://dx.doi.org/10.5114/ada.2022.114925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704456/
https://www.ncbi.nlm.nih.gov/pubmed/36457683
http://dx.doi.org/10.5114/ada.2022.114925

Ejemplares similares